{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:40:48Z","timestamp":1794667248379,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009398","name":"International Foundation for Functional Gastrointestinal Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1053\/j.gastro.2023.03.214","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:33:46Z","timestamp":1684474426000},"page":"1086-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation"],"prefix":"10.1053","volume":"164","author":[{"given":"Lin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Chey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Imdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Almario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil E.","family":"Bharucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2023.03.214_bib1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom","volume":"158","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41575-019-0222-y","article-title":"Management of functional constipation in children and adults","volume":"17","author":"Vriesman","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.03.214_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib4","first-page":"273","article-title":"A\u00a0case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort","volume":"20","author":"Herrick","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1053\/j.gastro.2023.03.214_bib5","first-page":"S63","article-title":"Managing costs and care for chronic idiopathic constipation","volume":"25","author":"McCormick","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.gastro.2023.03.214_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.gastro.2012.10.029","article-title":"American Gastroenterological Association medical position statement on constipation","volume":"144","author":"Lembo","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: A systematic review and network meta-analysis","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.03.214_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.14309\/ajg.0000000000001222","article-title":"Efficacy and safety of over-the-counter therapies for chronic constipation: An updated systematic review","volume":"116","author":"Rao","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib9","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1007\/s12325-017-0633-5","article-title":"The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) study: Results of an online questionnaire","volume":"34","author":"Harris","year":"2017","journal-title":"Adv Ther"},{"key":"10.1053\/j.gastro.2023.03.214_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243318","article-title":"Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications","volume":"16","author":"Lacy","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2023.03.214_bib11","series-title":"Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1053\/j.gastro.2023.03.214_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines international network: Principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Schunemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2023.03.214_bib13","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: Systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Schunemann","year":"2014","journal-title":"CMAJ"},{"key":"10.1053\/j.gastro.2023.03.214_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: Management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/apt.13662","article-title":"Systematic review with meta-analysis: Effect of fibre supplementation on chronic idiopathic constipation in adults","volume":"44","author":"Christodoulides","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.03.214_bib17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2016-311835","article-title":"Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: A systematic review and network meta-analysis","volume":"66","author":"Nelson","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.03.214_bib18","series-title":"EndNote 20","year":"2013"},{"key":"10.1053\/j.gastro.2023.03.214_bib20","doi-asserted-by":"crossref","first-page":"k4817","DOI":"10.1136\/bmj.k4817","article-title":"When continuous outcomes are measured using different scales: Guide for meta-analysis and interpretation","volume":"364","author":"Murad","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2023.03.214_bib21","series-title":"Version 5.3. The Nordic Cochrane Centre","year":"2014"},{"key":"10.1053\/j.gastro.2023.03.214_bib22","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2023.03.214_bib23","unstructured":"McMaster University. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. Evidence Prime: Krak\u00f3w, Poland, 2020. Available at: gradepro.org. Accessed January 31,\u00a02023."},{"key":"10.1053\/j.gastro.2023.03.214_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2023.03.214_bib25","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2023.03.214_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02065421","article-title":"Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial","volume":"40","author":"Badiali","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib27","first-page":"123","article-title":"Microbiota benefits after inulin and partially hydrolyzed guar gum supplementation: A randomized clinical trial in constipated women","volume":"27","author":"Linetzky Waitzberg","year":"2012","journal-title":"Nutr Hosp"},{"key":"10.1053\/j.gastro.2023.03.214_bib28","first-page":"12","article-title":"The effect of a fibre enriched dietary milk product in chronic primary idiopathic constipation [in Spanish]","volume":"23","author":"Lopez Roman","year":"2008","journal-title":"Nutr Hosp"},{"key":"10.1053\/j.gastro.2023.03.214_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2036.1995.tb00433.x","article-title":"Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation","volume":"9","author":"Ashraf","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.03.214_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1742-1241.1986.tb07949.x","article-title":"A\u00a0general practice study of the efficacy of Regulan in functional constipation","volume":"40","author":"Fenn","year":"1986","journal-title":"Br J Clin Pract"},{"key":"10.1053\/j.gastro.2023.03.214_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000200705","article-title":"A\u00a0double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation","volume":"49","author":"Odes","year":"1991","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2023.03.214_bib32","first-page":"1401","article-title":"Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"J\u00a0Nutr"},{"key":"10.1053\/j.gastro.2023.03.214_bib33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/nu5041417","article-title":"Fiber and prebiotics: Mechanisms and health benefits","volume":"5","author":"Slavin","year":"2013","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2023.03.214_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JXX.0000000000000346","article-title":"Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation","volume":"32","author":"McRorie","year":"2020","journal-title":"J\u00a0Am Assoc Nurse Pract"},{"key":"10.1053\/j.gastro.2023.03.214_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2013.73","article-title":"Association of low dietary intake of fiber and liquids with constipation: Evidence from the National Health and Nutrition Examination Survey","volume":"108","author":"Markland","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib36","first-page":"727","article-title":"Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation","volume":"45","author":"Anti","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.46.4.522","article-title":"Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation","volume":"46","author":"Corazziari","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.03.214_bib38","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/BF02087913","article-title":"Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation","volume":"41","author":"Corazziari","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1572-0241.2007.01199.x","article-title":"A\u00a0randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation","volume":"102","author":"Dipalma","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3533504","article-title":"Polyethylene glycol 3350 in the treatment of chronic idiopathic constipation: Post hoc analysis using FDA endpoints","volume":"2022","author":"Menees","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.03.214_bib41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/apt.12278","article-title":"Randomised clinical trial: macrogol\/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation: A comparison in a controlled environment","volume":"37","author":"Cinca","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.03.214_bib42","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1572-0241.2007.01365.x","article-title":"A\u00a0randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation","volume":"102","author":"Di Palma","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5056\/jnm18194","article-title":"A\u00a0randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation","volume":"25","author":"Mori","year":"2019","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.14309\/ajg.0000000000000942","article-title":"Senna versus magnesium oxide for the treatment of chronic constipation: A randomized, placebo-controlled trial","volume":"116","author":"Morishita","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib45","first-page":"167","article-title":"Basic biochemistry and physiology of magnesium: A brief review","volume":"10","author":"Altura","year":"1991","journal-title":"Magnes Trace Elem"},{"key":"10.1053\/j.gastro.2023.03.214_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/sdi.12411","article-title":"Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease","volume":"28","author":"Felsenfeld","year":"2015","journal-title":"Semin Dial"},{"key":"10.1053\/j.gastro.2023.03.214_bib47","author":"Cascella"},{"key":"10.1053\/j.gastro.2023.03.214_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1532-5415.1978.tb01967.x","article-title":"Lactulose syrup assessed in a double-blind study of elderly constipated patients","volume":"26","author":"Sanders","year":"1978","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1053\/j.gastro.2023.03.214_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.9.1.84","article-title":"Treatment of chronic constipation with lactulose syrup: Results of a double-blind study","volume":"9","author":"Wesselius-De Casparis","year":"1968","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.03.214_bib50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4239\/wjd.v12.i6.893","article-title":"Blood glucose response after oral lactulose intake in type 2 diabetic individuals","volume":"12","author":"Pieber","year":"2021","journal-title":"World J Diabetes"},{"key":"10.1053\/j.gastro.2023.03.214_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cgh.2011.03.026","article-title":"Oral bisacodyl is effective and well-tolerated in patients with chronic constipation","volume":"9","author":"Kamm","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.03.214_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ajg.2010.41","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation","volume":"105","author":"Mueller-Lissner","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13311","article-title":"bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in\u00a0vitro","volume":"30","author":"Krueger","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib55","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1002\/(SICI)1099-1573(1998)12:1+<S143::AID-PTR277>3.0.CO;2-G","article-title":"A\u00a0safe and effective drug","volume":"12","author":"Mascolo","year":"1998","journal-title":"Phytotherapy Res"},{"key":"10.1053\/j.gastro.2023.03.214_bib57","article-title":"Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity?","volume":"2009","author":"Morales","year":"2009","journal-title":"J\u00a0Toxicol"},{"key":"10.1053\/j.gastro.2023.03.214_bib58","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10620-009-1068-x","article-title":"Efficacy and safety of lubiprostone in patients with chronic constipation","volume":"55","author":"Barish","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cgh.2014.08.026","article-title":"Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation","volume":"13","author":"Fukudo","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.03.214_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2007.01524.x","article-title":"Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation","volume":"103","author":"Johanson","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib61","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10620-018-5027-2","article-title":"Painful and painless constipation: All roads lead to (A change in) Rome","volume":"63","author":"Bharucha","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib62","doi-asserted-by":"crossref","first-page":"G942","DOI":"10.1152\/ajpgi.00264.2005","article-title":"Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers","volume":"290","author":"Camilleri","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.gastro.2023.03.214_bib63","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1007\/s10620-017-4680-1","article-title":"Analysis of nausea in clinical studies of lubiprostone for the treatment of constipation disorders","volume":"62","author":"Cryer","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.03.214_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ajg.2017.230","article-title":"Low-dose linaclotide (72 \u03bcg) for chronic idiopathic constipation: A 12-week, randomized, double-blind, placebo-controlled trial","volume":"113","author":"Schoenfeld","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5056\/jnm17112","article-title":"Lower and upper gastrointestinal symptoms differ between individuals with irritable bowel syndrome with constipation or chronic idiopathic constipation","volume":"24","author":"Shah","year":"2018","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib67","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.14309\/ajg.0000000000001334","article-title":"Efficacy of linaclotide in reducing abdominal symptoms of bloating, discomfort, and pain: A phase 3B trial using a novel abdominal scoring system","volume":"116","author":"Chang","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ajg.2017.495","article-title":"Efficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: A systematic review and meta-analysis","volume":"113","author":"Shah","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.14309\/ajg.0000000000000530","article-title":"Evaluating when and why patients discontinue chronic therapy for irritable bowel syndrome with constipation and chronic idiopathic constipation","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib71","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10620-020-06187-5","article-title":"Plecanatide is effective and safe in the treatment for chronic idiopathic constipation: Results of a phase II trial","volume":"66","author":"Barish","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2023.03.214_bib72","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/1756283X17734697","article-title":"Randomized clinical trial: Efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation","volume":"10","author":"DeMicco","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib73","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2016.611","article-title":"A\u00a0randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation","volume":"112","author":"Miner","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: Results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib75","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A\u00a0placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2023.03.214_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2012.01983.x","article-title":"Prucalopride in the treatment of chronic constipation in patients from the Asia-pacific region: A randomized, double-blind, placebo-controlled study","volume":"24","author":"Ke","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2008.03884.x","article-title":"Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: A 12-week, randomized, double-blind, placebo-controlled study","volume":"29","author":"Quigley","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.03.214_bib78","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.03.214_bib79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2015.115","article-title":"A\u00a0randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation","volume":"110","author":"Yiannakou","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib80","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2019.12.034","article-title":"Mechanisms, evaluation, and management of chronic constipation","volume":"158","author":"Bharucha","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.03.214_bib81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/nmo.12505","article-title":"Association between health-related quality of life and symptoms in patients with chronic constipation: An integrated analysis of three phase 3 trials of prucalopride","volume":"27","author":"Tack","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14040","article-title":"High-resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: An acute, open label, randomized, crossover, reader-blinded study with potential clinical implications","volume":"33","author":"Corsetti","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib83","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/nmo.12019","article-title":"High amplitude propagated contractions","volume":"24","author":"Bharucha","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2023.03.214_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14309\/ajg.0000000000001962","article-title":"Constipation, hemorrhoids, and anorectal disorders in pregnancy","volume":"117","author":"Rao","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib87","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.14309\/ajg.0000000000001507","article-title":"ACG clinical guidelines: Management of benign anorectal disorders","volume":"116","author":"Wald","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib88","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.clnu.2022.10.015","article-title":"Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"van der Schoot","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1053\/j.gastro.2023.03.214_bib89","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.14309\/ajg.0000000000001403","article-title":"Evaluating the impact of cost on the treatment algorithm for chronic idiopathic constipation: Cost-effectiveness analysis","volume":"116","author":"Shah","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.03.214_bib90","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14309\/ajg.0000000000001728","article-title":"2021 national survey on prior authorization burden and its impact on gastroenterology practice","volume":"117","author":"Shah","year":"2022","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523005139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523005139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:42:01Z","timestamp":1758037321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508523005139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0016508523005139"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2023.03.214","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2023.03.214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Gastroenterological Association and the American College of Gastroenterology.","name":"copyright","label":"Copyright"}]}}